
501 - 1000 employees
Founded 2001
đ§Ź Biotechnology
đ Pharmaceuticals
âïž Healthcare Insurance
Biotechnology âą Pharmaceuticals âą Healthcare Insurance
Asklepios BioPharmaceutical, Inc. (AskBio) is a leading gene therapy company focused on developing treatments for debilitating genetic diseases. Wholly owned by Bayer AG, AskBio specializes in adeno-associated virus (AAV)-based gene therapies aimed at treating various neuromuscular, central nervous system, cardiovascular, and metabolic diseases. One of their notable developments is AB-1003 (LION-101), which has received FDA rare pediatric disease and orphan-drug designations for treating limb-girdle muscular dystrophy type 2I/R9. AskBio is dedicated to advancing genetic medicine, with a robust portfolio of clinical programs designed to bring innovative therapeutic options to patients worldwide.
đ May 19
501 - 1000
đ§Ź Biotechnology
đ Pharmaceuticals
âïž Healthcare Insurance
Associate Director, Patient Engagement at AskBio, focusing on advocacy for CNS diseases. Collaborating with patient communities in the United States to enhance clinical development programs.
đ May 19
501 - 1000
đ§Ź Biotechnology
đ Pharmaceuticals
âïž Healthcare Insurance
Associate Director of Patient Engagement at AskBio, leading Europe-based patient advocacy engagements and collaborations to understand patient needs. Driving strategic projects aligned with clinical development programs.
đ May 8
501 - 1000
đ§Ź Biotechnology
đ Pharmaceuticals
âïž Healthcare Insurance
VP of GDNF Clinical Development leading clinical development strategy for gene therapy programs. Managing team and fostering cross-functional collaboration for regulatory approvals and launches.
đ February 26
501 - 1000
đ§Ź Biotechnology
đ Pharmaceuticals
âïž Healthcare Insurance
Medical Director leading clinical development strategy in gene therapy for movement disorders. Overseeing clinical trials and collaborating with cross-functional teams in a biotech environment.